IBRONIL ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  11.0% 16.6% 13.5% 12.3% 18.7%  
Credit score (0-100)  23 10 15 18 6  
Credit rating  BB BB BB BB B  
Credit limit (kDKK)  0.0 0.0 0.0 0.0 -0.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Gross profit  -0.7 -8.5 3.3 -5.0 -2,706  
EBITDA  -0.7 -8.5 3.3 -5.0 -2,706  
EBIT  -0.7 -8.5 3.3 -5.0 -2,706  
Pre-tax profit (PTP)  117.6 111.2 128.3 128.7 -2,694.7  
Net earnings  117.6 111.2 128.3 128.7 -2,694.7  
Pre-tax profit without non-rec. items  118 111 128 129 -2,695  

 
See the entire income statement

Balance sheet (kDKK) 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Tangible assets total  0.0 0.0 0.0 0.0 0.0  
Shareholders equity total  3,213 3,324 3,453 3,581 712  
Interest-bearing liabilities  233 160 81.5 0.0 0.0  
Balance sheet total (assets)  3,471 3,509 3,547 3,594 724  

Net Debt  -14.4 5.8 -78.7 -56.8 -50.8  
 
See the entire balance sheet

Volume 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  -0.7 -8.5 3.3 -5.0 -2,706  
Gross profit growth  93.7% -1,170.5% 0.0% 0.0% -54,009.7%  
Employees  0 0 0 0 0  
Employee growth %  0.0% 0.0% 0.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  3,471 3,509 3,547 3,594 724  
Balance sheet change%  -3.3% 1.1% 1.1% 1.3% -79.8%  
Added value  -0.7 -8.5 3.3 -5.0 -2,706.0  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  0 0 0 0 0  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  -3.0 -4.0 1.0 -1.0 -2.0  

Profitability 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  100.0% 100.0% 100.0% 100.0% 100.0%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  3.5% 3.5% 3.9% 3.7% -124.8%  
ROI %  3.5% 3.5% 3.9% 3.7% -125.5%  
ROE %  3.5% 3.4% 3.8% 3.7% -125.5%  

Solidity 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Equity ratio %  92.6% 94.8% 97.3% 99.6% 98.2%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  2,156.6% -68.5% -2,402.5% 1,135.1% 1.9%  
Gearing %  7.2% 4.8% 2.4% 0.0% 0.0%  
Net interest  0 0 0 0 0  
Financing costs %  4.9% 4.7% 6.5% 10.3% 0.0%  

Liquidity 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Quick Ratio  13.5 19.1 37.6 281.6 56.8  
Current Ratio  13.5 19.1 37.6 281.6 56.8  
Cash and cash equivalent  247.0 154.6 160.2 56.8 50.8  

Capital use efficiency 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  3,213.2 3,324.4 3,452.7 3,581.4 711.7  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Net sales / employee  0 0 0 0 0  
Added value / employee  0 0 0 0 0  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  0 0 0 0 0  
EBIT / employee  0 0 0 0 0  
Net earnings / employee  0 0 0 0 0